Overview
- Accolades
-
-
Board Certified in Medical Oncology
-
Pleural and Lung Cancer
-
20+ Years of Experience
-
She is involved in experimental therapeutics of lung, head and neck cancers. Sabichi helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.
Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.
See More Top Mesothelioma DoctorsDisclaimer: Dr. Anita Lyn Sabichi has no professional affiliation with Asbestos.com.
Share this article
Last Modified October 17, 2018
Tim Povtak
Senior Content Writer
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.
1 Cited Article Sources
- Baylor College of Medicine. (n.d.). Anita Lyn Sabichi, M.D. Retrieved from: https://www.bcm.edu/people/view/anita-sabichi-m-d/b24cba2b-ffed-11e2-be68-080027880ca6
